You are here

  • Home
  • Archive
  • Volume 14, Issue Suppl 1
  • PHASE I/II DOSE-ESCALATION TRIAL OF PATUPILONE EVERY 3 WEEKS IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY OVARIAN, PRIMARY FALLOPIAN, OR PRIMARY PERITONEAL CANCER

Article Text

Article menu
Abstract
Posters October 5
PHASE I/II DOSE-ESCALATION TRIAL OF PATUPILONE EVERY 3 WEEKS IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY OVARIAN, PRIMARY FALLOPIAN, OR PRIMARY PERITONEAL CANCER

https://doi.org/10.1136/ijgc-00009577-200409001-00468

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.